Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 7, 1998, Pages 1227-1232

  Kikuchi, Masashi ^a   Kashii, Satoshi ^a   Mandai, Michiko ^a   Yasuyoshi, Hiroki ^a   Honda, Yoshihito ^a   Kaneda, Katsuyuki ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM ION; CALCIUM IONOPHORE; CYCLOSPORIN A; FK 506 BINDING PROTEIN; GLUTAMIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RAPAMYCIN; TACROLIMUS; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA CELL;

EID: 0031806507     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces, II: immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987;40:1256-1265.
2. Steiner J, Dawson TM, Fotuhi M, et al. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 1992; 358:584-587.
3. Ferreira PA, Hom JT, Pak WL. Retina specifically expressed novel subtypes of bovine cyclophilin. J Biol Chem. 1995;270:23179-23188.
4. Baker EK, Colley NJ, Zuker CS. The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J. 1994;13:4886-4895.
5. Kitagawa H, Hotta Y, Fujiki K, Kanai A. Cloning and high expression of rabbit FKBP25 in cornea. Jpn J Ophthalmol. 1996;40:133-141.
6. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 1994; 371:336-339.
7. Zhang J, Steiner JP. Nitric oxide synthase, immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. Neurol Res. 1995;17:285-288.
8. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity (see comments). Proc Natl Acad Sci USA. 1993;90:9808-9812.
9. Manev H, Favaron M, Candeo P, Fadda E, Lipartiti M, Milani D. Macrolide antibiotics protect neurons in culture against the N-methyl-D-aspartate (NMDA) receptor-mediated toxicity of glutamate. Brain Res. 1993;624:331-335.
10. Aizenman E, Frosch MP, Lipton SA. Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat. J Physiol (Lond). 1988;396:75-91.
11. Bloomfield SA, Dowling JE. Roles of aspartate and glutamate in synaptic transmission in rabbit retina, II: inner plexiform layer. J Neurophysiol. 1985;53:714-725.
12. Bloomfield SA, Dowling JE. Roles of aspartate and glutamate in synaptic transmission in rabbit retina, I: outer plexiform layer. J Neurophysiol. 1985;53:699-713.
13. David P, Lusky M, Teichberg VI. Involvement of excitatory neuro-transmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res. 1988;46: 657-662.
14. Mosinger JL, Olney JW. Photothrombosis-induced ischemic neuronal degeneration in the rat retina. Exp Neurol. 1989;105:110-113.
15. Louzada-Junior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem. 1992; 59:358-363.
16. Kashii S, Mandai M, Kikuchi M, et al. Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res. 1996;711:93-101.
17. Kashii S, Takahashi M, Mandai M, et al. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest Ophthalmol Vis Sci. 1994;35:685-695.
18. Kikuchi M, Kashii S, Honda Y, et al. Protective action of zinc against glutamate neurotoxicity in cultured retinal neurons. Invest Ophthalmol Vis Sci. 1995;36:2048-2053.
19. Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y. The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. Invest Ophthalmol Vis Sci. 1994;35:3673-3680.
20. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1996;37:826-832.
21. Kikuchi M, Kashii S, Honda Y, Tamura Y, Kaneda K, Akaike A. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci. 1997;38:848-854.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
23. Bram R, Hung D, Martin P, Schreiber S, Crabtree G. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol. 1993;13:4760-4769.
24. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit. 1995;17:584-591.
25. Abraham R, Wiederrecht G. Immunopharmacology of rapamycin. Annu Rev Immunol. 1996;14:483-510.
26. Langrehr JM, Muller AR, Markus PM, Simmons RL, Hoffman RA. FK 506 inhibits nitric oxide production by cells infiltrating sponge matrix allografts. Transplant Proc. 1991;23:3260-3261.
27. Conde M, Andrade J, Bedoya FJ, Santa-Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages: evidence of a direct effect on nitric oxide synthase activity. Immunology. 1995;84:476-481.